Bridgefront Capital’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,023
Closed -$84.5K 528
2023
Q4
$84.5K Buy
+10,023
New +$116K 0.06% 343

Other funds holding REPL

Bridgefront Capital's REPL Position: Q1 2024 in Review

Bridgefront Capital sold out of Replimune Group (REPL) in Q1 2024, closing a stake of 10,023 shares — an estimated $84.5K sold.

Bridgefront Capital first reported a position in REPL in Q4 2023 and held it in 1 quarter. The position peaked at $84.5K in Q4 2023. 150 funds tracked by Wall St. Rank hold REPL as of Q1 2024.

  • Bridgefront Capital reported no remaining Replimune Group position as of Q1 2024 after selling out during the quarter.
  • Bridgefront Capital sold 10,023 Replimune Group shares in Q1 2024, an estimated $84.5K.
  • Bridgefront Capital first reported a position in Replimune Group in Q4 2023 and held it in 1 quarter.
  • Bridgefront Capital's Replimune Group position peaked at $84.5K in Q4 2023.
  • 150 funds tracked by Wall St. Rank held Replimune Group as of Q1 2024.

Based on Bridgefront Capital's 13F filing for Q1 2024, filed 15 May 2024.